Sensus Healthcare, Inc. (SRTS) News

Sensus Healthcare, Inc. (SRTS): $9.17

0.65 (+7.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter SRTS News Items

SRTS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SRTS News Highlights

  • SRTS's 30 day story count now stands at 10.
  • Over the past 18 days, the trend for SRTS's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • APTX, BEAT and ESEA are the most mentioned tickers in articles about SRTS.

Latest SRTS News From Around the Web

Below are the latest news stories about Sensus Healthcare Inc that investors may wish to consider to help them evaluate SRTS as an investment opportunity.

Sensus Healthcare, Inc. (SRTS) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Yahoo | February 18, 2022

Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates

Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 10, 2022

Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter

4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively Affirms expectations for 1Q22 continued growth and full-year 2022 profitability Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for oncological and non-oncological conditions, announces financ

Yahoo | February 10, 2022

VeriSign (VRSN) to Report Q4 Earnings: What's in Store?

Higher .com and .net domain name registrations supported by a recovering global economy might have aided VeriSign's (VRSN) performance in the fourth quarter of 2021.

Yahoo | February 8, 2022

Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?

Sensus Healthcare, Inc. (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 3, 2022

Zacks.com featured highlights include: Sensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, Inc

Sensus Healthcare, Inc., Stride, Inc., Euroseas Ltd. and Vocera Communications, Inc are highlighted in this Screen of the Week article.

Yahoo | February 3, 2022

Here's Why "Trend" Investors Would Love Betting on Sensus Healthcare, Inc. (SRTS)

Sensus Healthcare, Inc. (SRTS) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Yahoo | February 2, 2022

Buy These 4 Low-Beta Stocks to Sail Through the Choppy Market

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Stride, Inc. (LRN), Euroseas Ltd. (ESEA) and Vocera (VCRA) are well poised to gain.

Yahoo | February 2, 2022

Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions

Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of SalesBOCA RATON, Fla, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the following promotions, all effective immediately: Vice President and General Counsel Michael J. Sardano has been promoted to President and Gene

Yahoo | January 31, 2022

Is Aptinyx Inc. (APTX) Outperforming Other Medical Stocks This Year?

Here is how Aptinyx Inc. (APTX) and Sensus Healthcare, Inc. (SRTS) have performed compared to their sector so far this year.

Yahoo | January 31, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6648 seconds.